Education & Training
Medical School
Kochi Medical School
Internship
- Beth Israel Medical Center-Petrie Division
- University of Hawaii School of Medicine
Residency
- Beth Israel Medical Center-Petrie Division
- University of Hawaii School of Medicine
Fellowship
- University of Missouri Kansas City
- University of Missouri Kansas City
Boards
American Board of Internal Medicine/Pulmonary Disease
American Board of Internal Medicine/Critical Care Medicine
Insurances
MU Health Care participates with most major managed care organizations. To find out whether MU Health Care is a participating provider in your insurance plan or network, or for information on co-payments and deductibles, please contact your insurance carrier directly.
Academic Information
Associate Professor of Medicine
Office
1 Hospital Drive
Columbia, MO 65212
United States
P. 573-882-2991
F. 573-884-1235
Research Interests
- Asthma, critical care medicine
- Pulmonary (lung) diseases
- Respiratory disorders
- Sleep disorders
- Chronic obstructive pulmonary disease (COPD)
- Pneumonia
Awards & Honors
- Passed Pulmonary Medicine Board Examination. September 09, 2009.
- "Top 30% Reviewer" for the Annals of Internal Medicine. 2008.
- Poster Finalist Award for work entitled, "Incremental Cost-effectiveness of Combination Inhaler Therapy in Moderate to Severe COPD" at the International Society for Pharmacoeconomics and Outcome Research Annual Meeting in Toronto, Ontario, Canada from May 2-7, 2008.
- Invited Ad Hoc Reviewer. British Medical Journal Point of Care Section. December 2007 - present.
- Editor. Cochrane Airways Group. Cochrane Collaborations, UK
Professional Societies
- Fellow, American College of Chest Physicians (2002-present)
- Member, American College of Chest Physicians (1997-present)
- Member, American Thoracic Society (1997-present)
Publications
- Oba Y, Keeney E, Ghatehorde N, Dias S. Dual combination therapy versus long‐acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2018 December 03. DOI:10.1002/14651858.CD012620.pub2
- Oba Y, Fadila M, Keeney E, Dias S. Fixed-dose combination inhalers compared to long-acting bronchodilators for COPD: a network meta-analysis (Protocol). Cochrane Database Syst Rev. 2017 March 29:CD012620. doi:10.1002/14651858.CD012620
- Oba Y, Chandran A, Devasahayam J. Long-acting muscarinic antagonist versus inhaled corticosteroid when added to Long-acting β-agonist for COPD: a meta-analysis. COPD. 2016 May 5:1-9. [Epub ahead of print]
- Oba Y, Sarva S, Dias S. Efficacy and safety of muscarinic antagonist-beta2 agonist bronchodilators: a network meta-analysis. Thorax. 2016 Jan;71(1):15-25. doi: 10.1136/thoraxjnl-2014-206732. Epub 2015 Oct 21.
- Oba Y, Lone N. Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression. Ther Adv Respir Dis. 2015, Vol. 9(1) 3–15.
- Oba Y, Lone N. Mortality benefit of vasopressor and inotropic agents in septic shock: A Bayesian network meta-analysis of randomized controlled trials. J Crit Care. 2014 Oct;29(5):706-10.
- Oba Y, Lone N. Comparative efficacy of inhaled corticosteroid and long-acting beta agonist combinations in preventing COPD exacerbations: a Bayesian network meta-analysis. Int J Chron Obstruct Pulmon Dis 2014:9 469–479